Quick Takeaways
- Michael James Newman filed SCHEDULE 13D/A for Indaptus Therapeutics, Inc. Common Stock, Par Value $0.01 Per Share (INDP).
- Disclosed ownership: 5.4%.
- Date of event: 22 Dec 2025.
Michael James Newman - 22 Dec 2025 SCHEDULE 13D/A Report for Indaptus Therapeutics, Inc. Common Stock, Par Value $0.01 Per Share (INDP)
- Filing Manager
- Michael James Newman
- Reporting Manager
- Newman Michael James
- Symbol
- INDP
- Shares outstanding
- 2,139,852 shares
- Disclosed Ownership
- 115,552 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13D/A
- Filing time
- 30 Dec 2025, 16:01:09 UTC
- Date of event
- 22 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Michael James Newman disclosed 5.4% ownership in Indaptus Therapeutics, Inc. Common Stock, Par Value $0.01 Per Share (INDP) on 22 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Dec 2025, 16:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Newman Michael James | 5.4% | 115,552 | 114,589 | 963 | /s/ Michael J. Newman | Michael J. Newman | 0001876315 |